MARKET

MBRX

MBRX

Moleculin Biotec
NASDAQ
0.4200
-0.0030
-0.71%
Opening 15:24 09/29 EDT
OPEN
0.4250
PREV CLOSE
0.4230
HIGH
0.4390
LOW
0.4080
VOLUME
40.16K
TURNOVER
0
52 WEEK HIGH
1.650
52 WEEK LOW
0.3377
MARKET CAP
12.52M
P/E (TTM)
-0.4142
1D
5D
1M
3M
1Y
5Y
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Investorplace · 3d ago
Weekly Report: what happened at MBRX last week (0918-0922)?
Weekly Report · 4d ago
Moleculin (MBRX) Posts Update From Lung Cancer Study, Stock Up
NASDAQ · 09/22 11:58
Moleculin Biotech Reports Independent Report Of No Cardiotoxicity In Annamycin
NASDAQ · 09/18 12:59
Weekly Report: what happened at MBRX last week (0911-0915)?
Weekly Report · 09/18 10:39
NKLA Stock Alert: Nikola Announces Canadian Expansion of Dealer Network
Investorplace · 09/15 13:51
Why Is Volcon (VLCN) Stock Down 32% Today?
Investorplace · 09/15 13:23
Why Is Axcella Health (AXLA) Stock Down 24% Today?
Investorplace · 09/15 13:01
More
About MBRX
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company. The Company has a pipeline of clinical programs for the treatment of tumors and viruses. It has three core technologies and six drug candidates, three of which have shown human activity in clinical trials. Its core technologies consist of Annamycin, WP1066 Portfolio and WP1122 Portfolio. Annamycin is designed to avoid multidrug resistance mechanisms and cardiotoxicity. Its WP1066 Portfolio (including lead drug candidates WP1066 and WP1220) represents a class of agents capable of hitting multiple targets, including the activated form of a key oncogenic transcription factor, STAT3. WP1066 is its flagship Immune/Transcription Modulator. An analog of WP1066, referred to as WP1220, is related to the use of the molecule in the topical treatment of psoriasis. Annamycin is in development for the treatment of refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.

Webull offers kinds of Moleculin Biotech Inc stock information, including NASDAQ:MBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MBRX stock methods without spending real money on the virtual paper trading platform.